Johns Hopkins surgeon and COVID contrarian Marty Makary selected to lead Trump’s FDA
President-elect Trump has picked Marty Makary, a Johns Hopkins’s surgeon who has espoused contrarian views about the COVID-19 pandemic, to lead the Federal Drug Administration. Makary is a surgical oncologist at Johns Hopkins University and an author.
‘We dodged a bullet’: Biotech and pharma react to selection of Marty Makary for FDA commissioner
It is fair to say that far more individuals aside from the commissioner are instrumental as far as the drug review and approval process in the U.S., but Makary we expect will promote technology and innovation in a way that offers some reprieve for those that feared a department more aligned with different virtues.
President-elect Trump announced on Friday that he is nominating Dr. Marty Makary, a Johns Hopkins School of Medicine ...
Medpage Today on MSN2d
What to Know About Marty Makary, Trump's Potential FDA PickMultiple reports suggest that president-elect Donald Trump is considering Marty Makary, MD, MPH, to run the FDA. Here's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback